Evotec SE (EVO)
NASDAQ: EVO · Real-Time Price · USD
2.185
+0.085 (4.05%)
Aug 12, 2026, 12:09 PM EDT - Market open
Evotec SE Market Cap
Evotec SE has a market cap or net worth of $760.14 million as of August 12, 2026. Its market cap has decreased by -45.87% in one year.
Market Cap
760.14M
Enterprise Value
694.02M
1-Year Change
-45.87%
Ranking
Category
Stock Price
$2.19
ChartMarket Cap Chart
Since the IPO on November 4, 2021, Evotec SE's market cap has decreased from $9.19B to $760.14M, a decrease of -91.73%. That is a compound annual growth rate of -40.69%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 11, 2026 | 760.14M | -33.13% |
| Dec 30, 2025 | 1.14B | -24.59% |
| Dec 30, 2024 | 1.51B | -63.78% |
| Dec 29, 2023 | 4.16B | 44.42% |
| Dec 30, 2022 | 2.88B | -65.81% |
| Dec 30, 2021 | 8.43B | -8.26% |
| Nov 4, 2021 | 9.19B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eton Pharmaceuticals | 1.15B |
| Cronos Group | 1.11B |
| Pacira BioSciences | 971.83M |
| Glass House Brands | 895.03M |
| Amphastar Pharmaceuticals | 868.62M |
| Collegium Pharmaceutical | 845.79M |
| Ironwood Pharmaceuticals | 710.53M |
| Tilray Brands | 648.24M |